KalVista Pharmaceuticals (KALV) Change in Cash (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Change in Cash of -$7.3 million in Q3 2025, up 79.51% quarter-over-quarter from -$35.7 million in Q2 2025, and down 12486.44% year-over-year from N/an in Q3 2024.
KalVista Pharmaceuticals' Change in Cash history runs 12 years deep, the most recent figure standing at -$7.3 million for Q3 2025.
- In Q3 2025, Change in Cash fell 12486.44% year-over-year to -$7.3 million; the TTM figure through Jul 2025 stood at -$33.2 million (down 88.97% YoY), while the FY2025 annual figure was $100.5 million, up 510.99% from the prior year.
- Change in Cash came in at -$7.3 million for Q3 2025 at KalVista Pharmaceuticals, up from -$35.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $46.5 million in Q1 2023 to a low of -$35.7 million in Q2 2025.
- A 5-year average of -$976111.1 and a median of -$427500.0 in 2022 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash surged 5183.59% in 2023 and plunged 12486.44% in 2025, its largest moves.
- KalVista Pharmaceuticals' Change in Cash stood at -$1.9 million in 2021, then surged by 138.98% to $722000.0 in 2022, then soared by 1043.63% to $8.3 million in 2023, then climbed by 17.88% to $9.7 million in 2024, then sank by 175.08% to -$7.3 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered -$7.3 million, -$35.7 million, and $9.7 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -7.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -7.31 Mn |
| Apr 30, 2025 | -35.67 Mn |
| Oct 31, 2024 | 9.73 Mn |
| Jul 31, 2024 | 59,000.00 |
| Apr 30, 2024 | 8.73 Mn |
| Jan 31, 2024 | -34.61 Mn |
| Oct 31, 2023 | 8.26 Mn |
| Jul 31, 2023 | -6.83 Mn |
| Apr 30, 2023 | -28.81 Mn |
| Jan 31, 2023 | 46.46 Mn |
| Oct 31, 2022 | 722,000.00 |
| Jul 31, 2022 | 7.13 Mn |
| Apr 30, 2022 | -14.85 Mn |
| Jan 31, 2022 | -914,000.00 |
| Oct 31, 2021 | -1.85 Mn |
| Jul 31, 2021 | -2.25 Mn |
| Apr 30, 2021 | 32.87 Mn |
| Jan 31, 2021 | 1.55 Mn |
| Oct 31, 2020 | -1.84 Mn |
| Jul 31, 2020 | 2.23 Mn |
| Apr 30, 2020 | -2.83 Mn |
| Jan 31, 2020 | -3.10 Mn |
| Oct 31, 2019 | -8.39 Mn |
| Jul 31, 2019 | -1.90 Mn |
| Apr 30, 2019 | -24.34 Mn |
| Jan 31, 2019 | -64.77 Mn |
| Oct 31, 2018 | 73.05 Mn |
| Jul 31, 2018 | -2.99 Mn |
| Apr 30, 2018 | -7.62 Mn |
| Jan 31, 2018 | 30.55 Mn |
| Oct 31, 2017 | 1.67 Mn |
| Jul 31, 2017 | -4.49 Mn |
| Apr 30, 2017 | -2.55 Mn |
| Jan 31, 2017 | 22.81 Mn |
| Oct 31, 2016 | -4.94 Mn |
| Jul 31, 2016 | -6.14 Mn |
| Mar 31, 2016 | -5.27 Mn |
| Dec 31, 2015 | -6.16 Mn |
| Sep 30, 2015 | -5.50 Mn |
| Jun 30, 2015 | 62.20 Mn |
| Mar 31, 2015 | -716,000.00 |
| Sep 30, 2014 | 2.15 Mn |
| Jun 30, 2014 | -2.10 Mn |
| Mar 31, 2014 | -505,000.00 |